The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Donafenib plus immune checkpoint inhibitors with or without oral fluorouracil chemotherapy drugs (S-1/capecitabine) for patients with resected high-risk biliary tract tumor: A multi-center retrospective study.
 
Huang Huaiyin
No Relationships to Disclose
 
Chuang Peng
No Relationships to Disclose
 
Zeng Xinxin
No Relationships to Disclose
 
Wang Zicheng
No Relationships to Disclose
 
Liming Shi
No Relationships to Disclose
 
Wang Zhao
No Relationships to Disclose
 
Jianjie Qin
No Relationships to Disclose
 
Hongji Yang
No Relationships to Disclose
 
Kai Chen
No Relationships to Disclose
 
Li Jian
No Relationships to Disclose